1. 浙江中医药大学第一临床医学院妇科,浙江,杭州,310006
2. 上海中医药大学附属曙光医院妇科,上海,201203
扫 描 看 全 文
竺卫达, 齐聪, 万怡婷. 齐氏养卵方治疗IVFET中卵巢储备功能下降患者的临床观察[J]. 上海中医药杂志, 2019,53(9):64-67.
ZHU Weida, QI Cong, WAN Yiting. Clinical observation of Qi’s Yangluan Decoction in the treatment of diminished ovarian reserve in IVF-ET[J]. Shanghai Journal of Traditional Chinese Medicine, 2019,53(9):64-67.
竺卫达, 齐聪, 万怡婷. 齐氏养卵方治疗IVFET中卵巢储备功能下降患者的临床观察[J]. 上海中医药杂志, 2019,53(9):64-67. DOI: 10.16305/j.1007-1334.2019.09.017.
ZHU Weida, QI Cong, WAN Yiting. Clinical observation of Qi’s Yangluan Decoction in the treatment of diminished ovarian reserve in IVF-ET[J]. Shanghai Journal of Traditional Chinese Medicine, 2019,53(9):64-67. DOI: 10.16305/j.1007-1334.2019.09.017.
目的:观察齐氏养卵方治疗体外受精(IVF)-胚胎移植(ET)中卵巢储备功能下降(DOR)患者的临床疗效。 方法:纳入准备行IVF-ET的DOR患者120例,采用随机数字表分为观察组和对照组,每组各60例。入组后,观察组患者给予齐氏养卵方口服,对照组患者给予脱氢表雄酮(DHEA)口服,治疗周期为3个月。治疗3个月后,两组患者均进入IVF-ET周期。比较两组患者治疗前后的血清基础卵泡刺激素(bFSH)、bFSH/黄体生成素(LH)、抗缪勒管激素(AMH)水平及窦卵泡数(AFC);在IVF-ET周期中,比较两组患者的促性腺激素(Gn)用量及使用天数、获卵数、成熟卵数、胚胎总数、优质胚胎数、成熟卵率、优质胚胎率、周期取消率、临床妊娠率。 结果:治疗后,两组患者的bFSH、bFSH/LH水平较治疗前均降低(P<0.05),AMH、AFC水平较治疗前均升高(P<0.05),且观察组患者的bFSH水平低于对照组(P<0.05)。在IVF-ET周期中,观察组患者的Gn用量较对照组明显减少(P<0.05),获卵数、成熟卵数、胚胎总数和优质胚胎数较对照组增加(P<0.05),且观察组患者的成熟卵率明显高于对照组(P<0.05)。 结论:齐氏养卵方能够显著改善DOR患者的卵巢储备功能,有效提高IVF-ET中的卵巢反应性,从而改善辅助生殖的助孕结局。
Objective:To observe the clinical efficacy of Qi’s Yangluan Decoction in treating patients with diminished ovarian reserve (DOR) in the course of in vitro fertilization and embryo transfer (IVF-ET). MethodsOne hundred and twenty patients with DOR who were prepared for IVF-ET were included and divided into the observation group and the control group by random number table, 60 cases in each group. After enrollment, the patients in the observation group were orally treated with Qi’s Yangluan Decoction, and the patients in the control group were orally treated with dehydroepiandrosterone (DHEA), with a course of three months. After treatment of 3 months, the patients in both groups entered the IVF-ET cycle. The levels of basal follicle stimulating hormone (bFSH), bFSH/luteinizing hormone (LH) and anti-mullerian hormone (AMH) and the antral follicle count (AFC) were compared between the two groups before and after treatment. During the IVF-ET cycle, the dosage of gonadotropin (Gn) and its use days, the numbers of the obtained ovum and the mature ovum, the total number of embryos, the number of high-quality embryos, the rates of mature ovum and the high-quality embryos, the cancellation rate of the cycle and the rate of clinical pregnancy were compared between the two groups. Results:After treatment, the levels of bFSH and bFSH/LH in the two groups were decreased compared with before treatment (P<0.05), the level of AMH and the AFC were increased compared with before treatment (P<0.05), and the level of bFSH in the observation group was lower than that in the control group (P<0.05). In the cycle of IVF-ET, the dosage of Gn in the observation group was significantly less than that in the control group (P<0.05), the numbers of the obtained ovums and the mature ovums, the total number of embryos and the number of high-quality embryos in the observation group were more than those in the control group (P<0.05), and the rate of mature ovum in the observation group were was obviously higher than that in the control group (P<0.05). Conclusion:Qi’s Yangluan Decoction can significantly improve the ovarian reserve function in patients with DOR, effectively enhance the ovarian responsiveness in the cycle of IVF-ET, and improve the outcome of assisted reproduction.
卵巢储备功能下降体外受精-胚胎移植齐氏养卵方
diminished ovarian reserveIVF-ETQi’s Yangluan Decoction
0
浏览量
275
下载量
0
CSCD
9
CNKI被引量
关联资源
相关文章
相关作者
相关机构